JMCR Partners
23
13M
18
2.30
12
0.22
3
- Areas of investment
Summary
JMCR Partners is the famous VC, which was founded in 2013. The leading representative office of defined VC is situated in the Shanghai. The fund was located in Asia if to be more exact in China.
The typical startup value when the investment from JMCR Partners is 1-5 millions dollars. The top amount of exits for fund were in 2019. Opposing the other organizations, this JMCR Partners works on 4 percentage points more the average amount of lead investments. Deals in the range of 5 - 10 millions dollars are the general things for fund. The important activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually.
The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Tekeluo Biotech, Viva Biotech, Riparian Pharmaceuticals. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Health Care, Clinical Trials. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.
The typical case for the fund is to invest in rounds with 3-4 participants. The meaningful sponsors for the fund in investment in the same round are Yingqi Investment, Xiamen Changrong Investment Management, Viva BioInnovator.
Investments analytics
Analytics
- Total investments
- 23
- Lead investments
- 12
- Exits
- 3
- Rounds per year
- 2.30
- Follow on index
- 0.22
- Investments by industry
- Biotechnology (10)
- Pharmaceutical (5)
- Health Care (5)
- Clinical Trials (3)
- Medical (3) Show 18 more
- Investments by region
-
- United States (14)
- China (4)
- Belgium (1)
- Peak activity year
- 2018
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 5B
- Group Appearance index
- 0.91
- Avg. company exit year
- 3
- Avg. multiplicator
- 5.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| VivaVision Biotech | 22 Sep 2016 | Early Stage Venture | 2M | Shanghai, China | |
| VivaVision Biotech | 26 Sep 2019 | Late Stage Venture | 10M | Shanghai, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.